Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Movement in Gastrocnemius Muscle
NCT03367429Phase 4Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Jun 2018
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in Spasticity, sponsored by Weill Cornell Medicine. Started Jun 2018; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT03367429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03367429.